---
schema_version: "secwatch.filing_event.v1"
accession: "0001323885-25-000005"
form_type: "8-K"
ticker: "ATRC"
cik: "0001323885"
company_name: "AtriCure, Inc."
filed_at: "2025-02-12T23:59:59+00:00"
generated_at: "2026-05-26T22:45:47.483006+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# AtriCure Q4 revenue $124.3M (+16.6% YoY); guides FY25 rev $517-527M

## Summary
- Q4 revenue $124.3M (+16.6%); full year revenue $465.3M (+16.5%).
- Q4 GAAP net loss $0.33/sh; adj. loss $0.08/sh; adj. EBITDA positive $12.7M.
- Full year 2024 adj. EBITDA $31.1M (vs $19.4M in 2023); adj. loss $0.67/sh (vs $0.75).
- Launched cryoSPHERE+, cryoSPHERE MAX, AtriClip FLEX-Mini in US, EnCompass clamp in Europe.
- FY2025 guidance: rev $517-527M; adj. EBITDA $42-44M; adj. loss $0.57-0.64/sh.

## SEC filing metadata
- accession: 0001323885-25-000005
- form_type: 8-K
- ticker: ATRC
- cik: 0001323885
- company_name: AtriCure, Inc.
- filed_at: 2025-02-12T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1323885/000132388525000005/0001323885-25-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1323885/000132388525000005/atrc-20250212.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001323885-25-000005
- JSON: https://secwatch.observer/filing/0001323885-25-000005.json
- Plain text: https://secwatch.observer/filing/0001323885-25-000005.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.